참고문헌
- Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ (2011). Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials, 32, 5906-14. https://doi.org/10.1016/j.biomaterials.2011.04.069
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007). Bioavailabilityofcurcumin:problemsandpromises. Mol Pharm, 4, 807-18 https://doi.org/10.1021/mp700113r
- Anestopoulos I, Voulgaridou GP, Georgakilas AG, et al (2015). Epigenetic therapy as a novel approach in hepatocellular carcinoma. J Pharmacol Exp Ther, 145, 103-19. https://doi.org/10.1016/j.pharmthera.2014.09.005
- Babaei E, Sadeghizadeh M, Hassan ZM, et al (2012). Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. Immuno pharmacol, 12, 223-6.
- Corney DC, Hwang CI, Matoso A, et al (2010). Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res, 16, 1119-28. https://doi.org/10.1158/1078-0432.CCR-09-2642
- De Lope CR, Tremosini S, Forner, Reig AM, Bruix J (2012). Management of HCC. J HepatoL, 8, 75-87.
- E-Serag HB, Rudolph KL (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27 https://doi.org/10.1056/NEJMra1001683
- Gavilan JCOG, Arnedo R, Puerta S (2013). Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C. Eur J Intern Med, 24, 846-51. https://doi.org/10.1016/j.ejim.2013.06.010
- Gopalan V, Pillai S, Ebrahimi F, et al (2014). Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Mol Carcinog, 53, 36-44. https://doi.org/10.1002/mc.21993
- Gupta SC, Kim JH, Kanappan R, et al (2011). Role of nuclear factor- kb-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol, 236, 658-71. https://doi.org/10.1258/ebm.2011.011028
- Kalimutho M, Di Cecilia S, Del Vecchio Blanco G, et al (2011). Epigenetically silenced miR-34b/c as a novel faecalbased screening marker for colorectal cancer. r J Cancer, 104, 1770-8. https://doi.org/10.1038/bjc.2011.82
- Klose RJ, Bird AP (2006). Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci, 31, 89-97. https://doi.org/10.1016/j.tibs.2005.12.008
- Kong D, Heath E, Chen W, et al (2012). Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. Am J Transl Res, 4, 14-23.
- Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008). Exploration of tumorsuppressivemicroRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res, 68, 2094-105. https://doi.org/10.1158/0008-5472.CAN-07-5194
- Kuboet T, Toyooka S, Tsukuda K, et al.. (2011). Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res, 17, 4965-74. https://doi.org/10.1158/1078-0432.CCR-10-3040
- Law PT, Wong N (2011). Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroentero Hepatol, 26, 437-49. https://doi.org/10.1111/j.1440-1746.2010.06512.x
- Lee YS, Dutta A (2009). MicroRNAs in cancer. Annu Rev Pathol, 4, 199-227. https://doi.org/10.1146/annurev.pathol.4.110807.092222
- Li XJ, Ren ZJ, Tang JH (2014). MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death Dis, 5, e1327. https://doi.org/10.1038/cddis.2014.270
- Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S (2011). Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One, 6, e24099. https://doi.org/10.1371/journal.pone.0024099
- Roy S, Levi E, Majumdar A, Sarkar FH (2012). Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J Hematol Oncol, 5, 1756-62.
- Sadeghizadeh M, Ranjbar B, Damaghi M, et al (2008). Dendrosomes as novel gene porters III. J Chem Technol Biotechnol, 6, 912-20.
- Tahmasebi Mirgani M, Isacchi B, Sadeghizadeh M, et al (2014). Dendrosomal curcumin nano formulation downregulates pluripotency genes via miR-145 activation in U87 MG glioblastoma cells. Int J Nanomed, 9, 403-17.
- Van Malenstein H, Van Pelt J, Verslype C (2011). Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer, 47, 1789-97 https://doi.org/10.1016/j.ejca.2011.04.027
- Yang H, Sherman IM, Su J, et al (2010). Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol, 28, 2437-44. https://doi.org/10.1200/JCO.2009.27.4456
- Yao z, Mishra L (2009). Cancer stem cells and hepatocellular carcinoma. Cancer Biol, 8, 1691-8. https://doi.org/10.4161/cbt.8.18.9843
- You JS, Jones PA (2012). Cancer genetics and epigenetics: two sides of the same coin?. Cancer Cell, 22, 9-20. https://doi.org/10.1016/j.ccr.2012.06.008
- Zamani M, Sadeghizadeha M, Behmanesh M, Najafi F(2015). Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer. Phytomedicine, 22, 961-7. https://doi.org/10.1016/j.phymed.2015.05.071
피인용 문헌
- Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network vol.44, pp.4, 2017, https://doi.org/10.1007/s11033-017-4115-2
- hmiR-34c-3p upregulation inhibits the proliferation of colon cancer cells by targeting EIF3D vol.29, pp.10, 2018, https://doi.org/10.1097/CAD.0000000000000674
- inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression vol.38, pp.3, 2018, https://doi.org/10.1042/BSR20180078